PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.48%
Negative revenue growth while 3141.T stands at 5.01%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.46%
Negative gross profit growth while 3141.T is at 12.44%. Joel Greenblatt would examine cost competitiveness or demand decline.
-24.95%
Negative EBIT growth while 3141.T is at 55.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-28.32%
Negative operating income growth while 3141.T is at 51.58%. Joel Greenblatt would press for urgent turnaround measures.
-25.47%
Negative net income growth while 3141.T stands at 62.04%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.47%
Negative EPS growth while 3141.T is at 62.03%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.47%
Negative diluted EPS growth while 3141.T is at 62.18%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.07%
10Y revenue/share CAGR under 50% of 3141.T's 153.57%. Michael Burry would suspect a lasting competitive disadvantage.
64.73%
5Y revenue/share CAGR at 75-90% of 3141.T's 78.99%. Bill Ackman would encourage strategies to match competitor’s pace.
32.48%
3Y revenue/share CAGR at 75-90% of 3141.T's 40.06%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
126.36%
Below 50% of 3141.T's 584.41%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
101.74%
Below 50% of 3141.T's 238.52%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
77.60%
3Y net income/share CAGR 75-90% of 3141.T's 99.12%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
195.62%
10Y equity/share CAGR at 50-75% of 3141.T's 286.86%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
123.30%
5Y equity/share CAGR 1.25-1.5x 3141.T's 91.40%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
57.64%
3Y equity/share CAGR 1.25-1.5x 3141.T's 41.84%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
266.67%
5Y dividend/share CAGR above 1.5x 3141.T's 170.00%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
144.44%
3Y dividend/share CAGR above 1.5x 3141.T's 68.75%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-3.70%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
5.46%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.01%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.68%
50-75% of 3141.T's 6.33%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-5.56%
We’re deleveraging while 3141.T stands at 2.68%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
0.60%
SG&A declining or stable vs. 3141.T's 5.45%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.